Royal Bank Of Canada Karyopharm Therapeutics Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 7,950 shares of KPTI stock, worth $5,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,950

Previous 56,357 85.89%

Holding current value

$5,088

Previous $49,000 87.76%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.06 $33,884 - $51,311	-48,407 Reduced 85.89%	7,950 $6,000
Q2 2024 Aug 14, 2024	SELL	$0.87 - $1.58 $70,169 - $127,434	-80,655 Reduced 58.87%	56,357 $49,000
Q1 2024 Nov 05, 2024	BUY	$0.72 - $1.66 $58,071 - $133,887	80,655 Added 143.11%	137,012 $206,000
Q1 2024 May 15, 2024	BUY	$0.72 - $1.66 $43,698 - $100,748	60,692 Added 79.52%	137,012 $206,000
Q4 2023 Feb 14, 2024	SELL	$0.68 - $1.31 $653 - $1,258	-961 Reduced 1.24%	76,320 $65,000
Q3 2023 Nov 14, 2023	SELL	$1.14 - $1.81 $18 - $28	-16 Reduced 0.02%	77,281 $103,000
Q2 2023 Aug 14, 2023	BUY	$1.79 - $4.59 $26,035 - $66,761	14,545 Added 23.18%	77,297 $138,000
Q1 2023 May 15, 2023	SELL	$2.84 - $3.92 $4,194 - $5,789	-1,477 Reduced 2.3%	62,752 $244,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $131,573 - $314,610	53,054 Added 474.76%	64,229 $218,000
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $8,755 - $12,489	-2,146 Reduced 16.11%	11,175 $61,000
Q2 2022 Aug 15, 2022	SELL	$4.15 - $8.37 $13,470 - $27,169	-3,246 Reduced 19.59%	13,321 $59,000
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $85,754 - $208,653	-14,510 Reduced 46.69%	16,567 $123,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $22,913 - $37,866	4,398 Added 16.48%	31,077 $200,000
Q3 2021 Nov 15, 2021	BUY	$4.45 - $10.63 $22,156 - $52,926	4,979 Added 22.94%	26,679 $155,000
Q2 2021 Aug 16, 2021	BUY	$8.11 - $11.11 $175,987 - $241,087	21,700 New	21,700 $224,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Karyopharm Therapeutics Inc. Transaction History